Regional Plans vs. National Giants

The 0.09% rate environment is a stress test, and different plan types fail at different pressure levels. National carriers, regional nonprofits, provider-sponsored plans, and PACE organizations each face the same CMS advance notice from a different structural position. Their chart review dependence, Star Rating profiles, administrative cost structures, provider network relationships, and access to delivery system revenue vary in ways that produce fundamentally different survival calculus under rate compression. This article maps who is most exposed, who has the strongest defensive position, and why the competitive landscape that emerges from the CY 2027 rate cycle will look substantially different from the one that entered it.

The rate compression does not operate uniformly because the MA market is not uniform. A national carrier managing 7 million members across 48 states faces a portfolio problem: some counties are profitable, others are not, and the 0.09% rate makes the unprofitable ones more unprofitable without meaningfully improving the profitable ones. A regional nonprofit serving 200,000 members in a single state faces a concentration problem: its entire business depends on the benchmark, provider, and enrollment dynamics of one market. A payvider faces neither problem in the same form, because its delivery system generates revenue that offsets insurance-side margin compression. Each structure has advantages and vulnerabilities that the current environment exposes.

National Carrier Exposure

#

The five largest MA carriers, UnitedHealth, Humana, CVS/Aetna, Cigna, and Centene, hold a combined share of approximately 60% of national MA enrollment. Their scale provides advantages that are real but bounded. Administrative costs per member decline as enrollment grows because fixed costs for compliance infrastructure, IT systems, and corporate overhead are spread across more lives. PBM integration, which UnitedHealth has through Optum Rx and CVS has through Caremark, provides pharmacy benefit management synergies that standalone insurers lack. Data analytics infrastructure at the scale these carriers operate enables population health modeling, utilization prediction, and bid optimization that smaller plans cannot replicate.

But scale does not fix a money-losing county. Every county in which an MA plan operates is a separate economic unit with its own benchmark, provider reimbursement environment, utilization profile, and competitive dynamics. A national carrier with a profitable MA book in Miami-Dade and a money-losing book in rural Alabama cannot transfer margin from one to the other in the bid; each county’s bid must stand on its own economics. Scale helps the carrier absorb temporary county-level losses while repositioning, but it does not make an unprofitable county profitable. When the rate environment compresses margin across the entire portfolio simultaneously, scale amplifies the aggregate loss rather than mitigating it.

The market exit calculus for national carriers involves balancing the financial cost of staying in unprofitable counties against the reputational and regulatory cost of leaving. CMS tracks plan exits and their impact on beneficiaries. Congressional offices receive constituent complaints when plans depart. State insurance commissioners notice when major carriers reduce their footprint. Exit creates negative publicity during the AEP when beneficiaries are selecting plans. But the financial cost of sustaining operations in a county where the benchmark does not cover the cost of care is concrete and recurring, while the reputational cost of exit is abstract and temporary. As the 0.09% rate environment persists, the financial calculus increasingly favors exit.

National carriers manage their county portfolios through a combination of benefit reduction, premium increase, network tightening, and selective exit. UnitedHealth’s 2026 contraction of 1.3 to 1.4 million members was a portfolio optimization exercise: exit the counties where margin was worst, reduce benefits in marginal counties, and concentrate resources in profitable geographies. Humana took the opposite approach for 2026, maintaining benefits and growing membership, but faces the same portfolio question for 2027 at a worse rate. The divergence in national carrier strategy, margin-first at UnitedHealth versus growth-first at Humana, will produce a natural experiment whose results will be visible in 2027 financial performance.

The chart review exclusion creates an additional differentiation among national carriers. Plans with the most aggressive chart review operations face the largest per-enrollee revenue reduction from the $7.2 billion exclusion. Mizuho’s identification of CVS/Aetna as particularly exposed suggests that chart review intensity is not uniform across national carriers, meaning the exclusion hits some national plans harder than others even at similar enrollment scale. The chart review exclusion functions as a within-tier sorting mechanism that penalizes coding-dependent business models regardless of carrier size.

Regional Nonprofit Advantages

#

ACHP’s membership of regional nonprofit health plans occupies a structurally different position under rate compression, and the advantages are not coincidental. They reflect decades of operational decisions that happen to align with the regulatory direction CMS is now pursuing.

Regional nonprofits historically relied less on aggressive retrospective coding than national carriers. Their chart review intensity is generally lower, meaning the $7.2 billion chart review exclusion removes less of their risk-adjusted revenue on a per-enrollee basis. ACHP’s initial statement on the advance notice noted that its nonprofit members spend 96 cents of every dollar on care delivery. That care delivery ratio is both a financial constraint (less margin) and a structural advantage (less dependence on coding-driven revenue that is now being excluded).

Higher Star Ratings concentration is another structural advantage. Many regional nonprofits hold 4-star or above ratings, securing the 5% quality bonus payment that functions as a material revenue supplement under rate compression. The QBP provides approximately $50 to $70 per member per month in additional benchmark-derived revenue for a 4-star plan in a moderate-benchmark county. In a 0.09% rate environment, that bonus is a larger share of total margin than in a 5% rate environment, making the 3.5-to-4-star threshold even more financially consequential. Regional nonprofits with stable 4-star or above ratings enter the CY 2027 cycle with a revenue floor that below-4-star national carriers do not have.

Tighter provider network management produces both clinical and financial advantages. Regional nonprofits operate smaller networks with deeper relationships. Providers who have contracted with the same plan for a decade or more have established referral patterns, care coordination protocols, and documentation practices that larger, more transactional national carrier networks do not replicate. Smaller networks are easier to manage for network adequacy, utilization management, and documentation quality. Under encounter-based RA, the depth of provider relationships becomes a risk score generation advantage because providers who understand the plan’s documentation needs and work collaboratively to capture clinically appropriate HCCs produce better encounter data quality than providers who view the plan as one of fifteen contracts they manage.

The resilience argument has historical support. Regional nonprofits survived the ACA-era rate compression between 2010 and 2015, a period when MA benchmarks were reduced to bring payments closer to FFS levels and multiple national carriers exited or scaled back their MA participation. Plans like Tufts Health Plan, Capital Health Plan, Group Health Cooperative, and others maintained market presence through a period that tested MA viability in ways similar to the current environment. The current rate compression is more severe in absolute terms because the chart review exclusion and V28 model changes operate on top of the rate rather than as part of it, but the structural advantages that carried regional nonprofits through the ACA period, lower overhead, deeper provider relationships, community reinvestment rather than shareholder return as the margin outlet, remain intact.

The vulnerability for regional nonprofits is concentration risk. A plan operating in a single state or a handful of counties has no geographic diversification. If the local benchmark environment is unfavorable, the local provider market consolidates and demands higher reimbursement, or a demographic shift changes the enrolled population’s risk profile, the regional plan has no other markets to offset the impact. National carriers can absorb a bad year in one state with a good year in another. Regional nonprofits cannot.

Provider-Sponsored Plans as Payviders

#

Provider-sponsored plans that operate as payviders represent the structural type best positioned for the current rate environment, for reasons that compound across every dimension of the rate and risk adjustment compression.

The defining characteristic is the shared balance sheet. When a health system owns an MA plan, the plan pays the health system for care delivered to enrolled members, and the combined entity manages total margin across both the insurance and delivery functions. Rate compression hits the plan side, reducing capitation revenue. But the delivery system captures the clinical volume those enrolled members generate, producing facility, professional, and ancillary revenue that offsets insurance margin pressure. A standalone insurer that loses $10 per member per month on its MA book has a $10 loss. A payvider whose plan loses $10 per member per month but whose delivery system earns $15 per member per month from the same members’ clinical utilization has a $5 net gain at the organizational level. The delivery system revenue buffer is the structural mechanism that gives payviders longer runway before exit becomes rational.

The encounter-based RA advantage deepens the structural differentiation. Payviders capture risk scores through internal documentation at the point of care because their clinicians are employees or closely integrated partners. No arm’s-length chart review process is needed. The chart review exclusion removes revenue payviders were not dependent on. The encounter-based RA future (MCR-02.04) would formalize a data architecture that payviders already operate under. Each step of the CMS risk adjustment reform trajectory, V28, chart review exclusion, encounter-based RA, widens the competitive gap between payviders and standalone insurers (MCR-05.02).

Kaiser Permanente is the original payvider at national scale, operating integrated delivery systems across multiple states with a clinical model that generates encounter data as a natural byproduct of care. Kaiser’s MA operations have not experienced the financial distress that the national carriers report because Kaiser’s cost structure is built around delivery system efficiency rather than coding-driven revenue optimization. UPMC in western Pennsylvania demonstrates the model in a competitive market where the plan and health system operate against independent competitors on both the insurance and provider sides. Geisinger in central Pennsylvania demonstrates the model in a rural setting where the payvider is often the only provider and the only plan, creating a local market position that rate compression cannot dislodge. CareOregon in the Pacific Northwest operates primarily in Medicaid managed care but is growing its Medicare presence, demonstrating the model’s applicability for organizations that originated on the Medicaid side and are expanding into Medicare.

The limitation of the payvider model is that it cannot be acquired overnight. UnitedHealth’s Optum, Humana’s CenterWell, and CVS’s Oak Street represent acquisition-based attempts to build payvider capabilities, but bolted-on delivery assets do not automatically produce the clinical integration that makes the model work. Kaiser’s integration was built over decades. Whether acquisition-assembled payvider structures can replicate its economics is the open strategic question for every national carrier (MCR-04.01).

PACE Positioning

#

PACE organizations occupy a niche within MA that the current rate environment may actually benefit, paradoxically, by disrupting the D-SNP market from which PACE draws its growth.

PACE operates under full capitation for a nursing-home-eligible population, bundling acute, post-acute, and long-term care services into a single comprehensive benefit. The payment structure blends Medicare and Medicaid capitation, meaning PACE rate-setting is partially insulated from the MA benchmark dynamics that drive standard MA plan economics. The V28 phase-in is slower for PACE (50/50 blend for CY 2027 versus 100% V28 for standard MA), and the chart review exclusion does not apply to PACE for CY 2027 (MCR-02.03). These accommodations reflect CMS’s recognition that PACE serves a population and operates a care model that cannot absorb the same rate compression timeline as standard MA.

The MA market disruption may create PACE growth opportunity. As D-SNPs exit counties or reduce benefits under rate compression, dual eligible beneficiaries in those markets lose access to integrated Medicare-Medicaid coverage. PACE, where available, offers a more comprehensive integration model than any D-SNP because PACE controls both the Medicare and Medicaid benefit under a single organizational structure. If D-SNP availability contracts in markets where PACE organizations operate, PACE may absorb dual eligible enrollment that the D-SNP market can no longer serve (MCR-09.06). PACE enrollment nationally is approximately 75,000 beneficiaries, a small fraction of the dual eligible population, but the model’s per-beneficiary cost savings for the frailest Medicare population are well documented, and expansion into markets where standard MA is retreating from dual eligible coverage could accelerate growth.

Where Disruption and Consolidation Are Headed

#

National carrier exits create enrollment pools. When UnitedHealth or Aetna leaves a county, the beneficiaries enrolled in those plans must choose alternative coverage during a Special Enrollment Period. Regional nonprofits and provider-sponsored plans with established presence in those counties are the natural beneficiaries of that displacement. The 2026 market exits have already demonstrated this dynamic: Humana’s million-member enrollment gain during the 2026 AEP was partly driven by capturing beneficiaries displaced from competitors’ exiting markets.

Tech-enabled plan models represent a speculative but real entrant category. Companies like Alignment Healthcare, Devoted Health, and Clover Health built MA business models around data analytics, clinical decision support, and value-based care delivery infrastructure designed to operate at lower administrative cost than legacy carriers. Whether data and automation can substitute for the margin that rate compression removes is the strategic question these companies face. Their enrollment bases are small relative to the national carriers, and several have struggled with profitability. But their cost structures may prove more adaptable to a low-rate environment than the legacy infrastructure of carriers built for a different era.

Consolidation dynamics will accelerate. The strategic logic of MA plan acquisitions changes under rate compression. A national carrier acquiring a regional nonprofit for its Star Ratings and provider relationships makes sense if the national carrier’s own Stars are deteriorating. A regional nonprofit acquiring another regional for geographic scale makes sense if the combined entity can spread administrative costs and negotiate more favorable provider rates. A health system acquiring an MA plan to complete a payvider conversion makes sense if the system has the clinical volume and population health capabilities to manage capitated risk. The regulatory approval landscape for MA plan acquisitions involves both state insurance commission review and CMS contract transfer approval, and the timeline for completing a deal, typically 6 to 12 months, means that acquisitions initiated in response to the CY 2027 rate environment will not be operational before CY 2028 at the earliest (MCR-04.08).

The competitive landscape emerging from the CY 2027 rate cycle will be defined by these structural dynamics. National carriers will be smaller, more geographically concentrated, and more dependent on delivery system integration through Optum, CenterWell, and Oak Street. Regional nonprofits will be proportionally stronger in the markets where they maintained presence while national carriers retreated. Payviders will have demonstrated, again, that the integrated model weathers rate compression better than any alternative. PACE will have grown modestly in markets where D-SNP availability contracted. The MA market will not have shrunk overall, but the composition of who operates within it will have shifted meaningfully toward organizations whose cost structures and care models align with the payment system CMS is building.

Related Reading

#

MCR-02_06 State-by-State Rate Impact Analysis: Top 20 Markets MCR-05_02 Becoming a Payvider: The Strategic Case for Provider Plan Ownership MCR-09_06 PACE at a Crossroads: Cost Profile, Quality Evidence, and the Post-FAI Opportunity